Search clinical trials for: Escitalopram Oxalate Tablets

Total 7627 results

Lupin Ltd.

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

Pharmacokinetic Study

India
KRL Hospital, Islamabad
Dow University of Health Sciences; Khyber Medical College, Peshawar; Quaid-e-Azam...

Completed

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Major Depressive Disorder

Pakistan
Laureate Institute for Brain Research, Inc.

Terminated

Adherence to Antidepressant Treatment in Subjects With Depression

Depression

United States
University of Texas Southwestern Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (TAKEDA)

Insomnia | Major Depressive Disorder

United States
University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
University of Washington
National Institutes of Health (NIH); Forest Laboratories

Terminated

Sinusitis and Facial Pain Disorders Anti-Depression Trial (SFPAT)

Depression | Chronic Sinusitis | Facial Pain Disorder

United States
Procter and Gamble

Completed

Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity

Dentinal Hypersensitivity

United States
Aveiro University

Completed

Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders

Speech Disorders

Portugal
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Treatment of Depression in Adults

Depression

United States, Italy
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Formulations of Entecavir

Hepatitis B
T. George Hornby
Shirley Ryan AbilityLab; University of Medicine and Dentistry of New Jersey

Completed

Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury

Spinal Cord Injury

United States
NYU Langone Health

Terminated

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

Alzheimer Disease

United States
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States
Western Galilee Hospital-Nahariya

Unknown

Dysbiosis in Localized Provoked Vulvodynia (LPV) (DMLPV)

Vulvodynia | Vulvar Vestibulitis
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Chronic Myeloid Leukemia | Gastrointestinal Stromal Tumor

Korea, Republic of
The Hospital for Sick Children
International Centre for Diarrhoeal Disease Research, Bangladesh; The Sprinkles...

Completed

Delivery Vehicles for Prenatal Calcium Supplementation

Pregnancy

Canada, Bangladesh
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Recruiting

Phase 1 Study of KH607 Tablets

Healthy

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B

Chronic Hepatitis b

China
Stanford University

Completed

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

Pancreatic Adenocarcinoma

United States
University of South Carolina

Completed

Escitalopram (Lexapro) for Depression MS or ALS

Multiple Sclerosis | Amyotrophic Lateral Sclerosis | Major Depression

United States
Max-Planck-Institute of Psychiatry

Completed

Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene

Pharmacokinetics

Germany
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

Anxiety Disorders | Generalized Anxiety Disorder

United States
Erzurum Regional Training & Research Hospital

Unknown

Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders

Anxiety Disorders | Major Depressive Disorder

Turkey
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Depressive Disorder, Major

China
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram (Lexapro) for the Treatment of Postpartum Depression (LexaproPPD)

Postpartum Depression

United States
Massachusetts General Hospital

Terminated

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

Anxiety Disorder

United States
Forest Laboratories

Completed

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Major Depressive Disorder

United States
Seoul National University Bundang Hospital
Ministry of Health & Welfare, Korea

Unknown

Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Duke University

Terminated

A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women

Depression | HIV

United States
Karolinska Institutet

Completed

A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram

Healthy

Sweden
Forest Laboratories

Completed

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Seoul National University Hospital

Completed

Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder

Obsessive Compulsive Disorder

Korea, Republic of
Sheba Medical Center

Unknown

A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression

Depressive Disorder, Major

Israel
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

Escitalopram in Schizophrenia in OCD- Open Label Study

Schizophrenia

Israel
BeerYaakov Mental Health Center

Unknown

Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study

Schizophrenia | OCD

Israel
Bispebjerg Hospital
H. Lundbeck A/S; The Danish Medical Research Council; Danish Heart Foundation

Unknown

DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome

Depression

Denmark
University of Southern Denmark
H. Lundbeck A/S

Completed

Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism

Healthy

Denmark
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
Janssen Research & Development, LLC

Completed

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

HIV-1

United States
InSightec

Active, not recruiting

Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

Essential Tremor

United States
University of Alabama at Birmingham

Active, not recruiting

Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion

Calcium Oxalate Urolithiasis

United States
InSightec

Active, not recruiting

ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease

Parkinson Disease

United States, Canada, United Kingdom, Korea, Republic of, Spain, Israel, Italy, Taiwan
InSightec

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

Parkinson Disease

Spain
Tri-Service General Hospital

Completed

Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems

Anxiety Disorders | Sleep Apnea

Taiwan
Kunming Medical University
Chinese Academy of Sciences

Completed

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

Depression | Depression Secondary to Other Disease

China
VA Nebraska Western Iowa Health Care System
Forest Laboratories

Completed

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

PTSD

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Treatment Response of Geriatric Depression (ERP)

Depression

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

fMRI Studies of Emotional Brain Circuitry in People With Major Depression

Depression
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms (Lexapro)

Depressive Disorder, Major

China
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Aging Brain Changes, Executive Dysfunction and Depression (FA)

Depression

Search clinical trials for: Escitalopram Oxalate Tablets

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations